These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 33149783

  • 1. CD14+ monocytes and CD163+ macrophages correlate with the severity of liver fibrosis in patients with chronic hepatitis C.
    Zhao SX, Li WC, Fu N, Kong LB, Zhang QS, Han F, Ren WG, Cui P, Du JH, Wang BY, Zhang YG, Wang RQ, Kong L, Nan YM.
    Exp Ther Med; 2020 Dec; 20(6):228. PubMed ID: 33149783
    [Abstract] [Full Text] [Related]

  • 2. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.
    Kazankov K, Barrera F, Møller HJ, Bibby BM, Vilstrup H, George J, Grønbaek H.
    Hepatology; 2014 Aug; 60(2):521-30. PubMed ID: 24623375
    [Abstract] [Full Text] [Related]

  • 3. Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology.
    Lund Laursen T, Brøckner Siggard C, Kazankov K, Damgaard Sandahl T, Møller HJ, Ong A, Douglas MW, George J, Tarp B, Hagelskjaer Kristensen L, Lund Laursen A, Hiramatsu A, Nakahara T, Chayama K, Grønbaek H.
    Scand J Gastroenterol; 2018 Aug; 53(8):986-993. PubMed ID: 29987961
    [Abstract] [Full Text] [Related]

  • 4. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
    El Aggan H, Farahat N, El Deeb N, Zeid A, El-Shendidi A.
    Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
    [Abstract] [Full Text] [Related]

  • 5. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
    Lidofsky A, Holmes JA, Feeney ER, Kruger AJ, Salloum S, Zheng H, Seguin IS, Altinbas A, Masia R, Corey KE, Gustafson JL, Schaefer EA, Hunt PW, Deeks S, Somsouk M, Chew KW, Chung RT, Alatrakchi N.
    J Infect Dis; 2018 Sep 22; 218(9):1394-1403. PubMed ID: 29868909
    [Abstract] [Full Text] [Related]

  • 6. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC, Liu CH, Lin CL, Wang PC, Tseng TC, Lin HH, Kao JH.
    J Formos Med Assoc; 2015 Oct 22; 114(10):923-8. PubMed ID: 26279173
    [Abstract] [Full Text] [Related]

  • 7. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
    Laursen TL, Wong GL, Kazankov K, Sandahl T, Møller HJ, Hamilton-Dutoit S, George J, Chan HL, Grønbaek H.
    J Gastroenterol Hepatol; 2018 Feb 22; 33(2):484-491. PubMed ID: 28618015
    [Abstract] [Full Text] [Related]

  • 8. Predicting Liver Fibrosis in the Hepatitis C Population: Concordance Analysis Between Noninvasive Scoring Systems and Percutaneous Liver Biopsy.
    Mada PK, Malus ME, Saldaña Koppel DA, Adley S, Moore M, Alam MJ, Feldman M.
    Cureus; 2020 Sep 11; 12(9):e10376. PubMed ID: 33062499
    [Abstract] [Full Text] [Related]

  • 9. Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.
    Andersen ES, Rødgaard-Hansen S, Moessner B, Christensen PB, Møller HJ, Weis N.
    Eur J Clin Microbiol Infect Dis; 2014 Jan 11; 33(1):117-22. PubMed ID: 24424890
    [Abstract] [Full Text] [Related]

  • 10. Soluble CD163 and CD163 Expression on Monocytes Associated with Chronic Hepatitis B Inflammation and HBsAg Loss.
    Xie P, Yao B, Huang D, Chen Y, Gong Q, Zhang X.
    J Clin Transl Hepatol; 2022 Dec 28; 10(6):1059-1067. PubMed ID: 36381085
    [Abstract] [Full Text] [Related]

  • 11. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.
    Dultz G, Gerber L, Farnik H, Berger A, Vermehren J, Pleli T, Zeuzem S, Piiper A, Kronenberger B, Waidmann O.
    J Viral Hepat; 2015 Apr 28; 22(4):427-32. PubMed ID: 25181653
    [Abstract] [Full Text] [Related]

  • 12. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q, Li W, Huang Y, Chen L.
    J Viral Hepat; 2016 Nov 28; 23(11):912-919. PubMed ID: 27375134
    [Abstract] [Full Text] [Related]

  • 13. Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
    Mueller JL, Feeney ER, Zheng H, Misdraji J, Kruger AJ, Alatrakchi N, King LY, Gelrud L, Corey KE, Chung RT.
    Clin Transl Gastroenterol; 2015 Oct 08; 6(10):e114. PubMed ID: 26448455
    [Abstract] [Full Text] [Related]

  • 14. microRNA-1273g-3p is a useful non-invasive test for the prediction of liver fibrosis in patients with chronic hepatitis C.
    Nan Y, Niu X, Wang R, Zhao S, Fu N, Du J, Wang Y, Wang B, Zhang Y.
    Exp Ther Med; 2019 Mar 08; 17(3):1817-1824. PubMed ID: 30783454
    [Abstract] [Full Text] [Related]

  • 15. [Effects of direct antiviral agent on the frequency of peripheral blood mononuclear cells and their activating factors sCD14s and CD163 in patients with chronic hepatitis C].
    Li JG, Zeng GF, Zeng YF, Li YT, Ning G, Lin CS, Zhang XH, Gao ZL.
    Zhonghua Gan Zang Bing Za Zhi; 2020 Dec 20; 28(12):1018-1022. PubMed ID: 34865349
    [Abstract] [Full Text] [Related]

  • 16. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
    Mascia C, Lichtner M, Zuccalà P, Vita S, Tieghi T, Marocco R, Savinelli S, Rossi R, Iannetta M, Campagna M, Schiavone F, Mengoni F, Russo G, Mastroianni CM, Vullo V.
    Clin Res Hepatol Gastroenterol; 2017 Dec 20; 41(6):644-655. PubMed ID: 28578937
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
    Köksal İ, Yılmaz G, Parlak M, Demirdal T, Kınıklı S, Candan M, Kaya A, Akhan S, Aydoğdu Ö, Turgut H, Gürbüz Y, Dağlı Ö, Gökal AA, Güner R, Kuruüzüm Z, Tarakçı H, Beslen N, Erdoğan S, Özdener F, Study Group TCHC.
    Turk J Gastroenterol; 2018 Jul 20; 29(4):464-472. PubMed ID: 30249562
    [Abstract] [Full Text] [Related]

  • 18. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A, Støy S, Thomsen KL, Hvas CL, Agnholt J, Dahlerup JF, Møller HJ, Grønbaek H.
    Scand J Immunol; 2014 Dec 20; 80(6):417-23. PubMed ID: 25346048
    [Abstract] [Full Text] [Related]

  • 19. Soluble CD163 Levels and CD163+CD14+ Monocyte/Macrophage Counts in Patients with Asthma.
    Zhi Y, Gao P, Li W, Gao F, Zhang J, Lin H, Zhang J.
    Iran J Immunol; 2018 Sep 20; 15(3):239-245. PubMed ID: 30246699
    [Abstract] [Full Text] [Related]

  • 20. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
    Lin CS, Chang CS, Yang SS, Yeh HZ, Lin CW.
    Intern Med; 2008 Sep 20; 47(7):569-75. PubMed ID: 18379139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.